Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov;42(12):2325-2332.
doi: 10.1038/npp.2017.131. Epub 2017 Jun 23.

Striatal Dopamine D2/D3 Receptor Availability Varies Across Smoking Status

Affiliations

Striatal Dopamine D2/D3 Receptor Availability Varies Across Smoking Status

Corinde E Wiers et al. Neuropsychopharmacology. 2017 Nov.

Abstract

To assess how tobacco smoking status affects baseline dopamine D2/D3 (D2R) receptor availability and methylphenidate-induced dopamine (DA) release, we retrospectively analyzed D2R availability measures of 8 current smokers, 10 ex-smokers, and 18 nonsmokers who were scanned with positron emission tomography and [11C]raclopride, after administration of an injection of placebo or 0.5 mg/kg i.v. methylphenidate. There was a significant effect of smoking status on baseline striatal D2R availability; with current smokers showing lower striatal D2R availability compared with nonsmokers (caudate, putamen, and ventral striatum) and with ex-smokers (caudate and putamen). Baseline striatal D2R did not differ between nonsmokers and ex-smokers. The effect of smoking status on methylphenidate-induced DA release tended to be lower in smokers but the difference was not significant (p=0.08). For behavioral measures, current smokers showed significantly higher aggression scores compared with both nonsmokers and ex-smokers. These results suggest that with abstinence ex-smokers may recover from low striatal D2R availability and from increased behavioral aggression seen in active smokers. However, longitudinal studies are needed to assess this within abstaining smokers.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Smoking status had a significant effect on striatal D2R availability (p=0.004), with post hoc tests showing reduced D2R availability in smokers versus nonsmokers (caudate p=0.015, putamen p=0.035, ventral striatum p=0.012) and ex-smokers (caudate p=0.05 and putamen p=0.03). The post hoc effects did not meet Bonferroni correction for multiple comparisons (all p>0.006). Error bars represent 1 SEM. Statistics were corrected for age and BMI. BPND, nondisplaceable binding potential; D2R, dopamine D2/D3 receptor.
Figure 2
Figure 2
Methylphenidate-induced DA release varied over smoking status at trend level (p=0.08). Exploratory post hoc tests showed increased DA release in ex-smokers compared with current smokers at trend level for caudate (p=0.08) and putamen (p=0.06), and compared with nonsmokers in caudate (p=0.04), putamen (p=0.03), and VS (p=0.08). The post hoc effects did not meet Bonferroni correction for multiple comparisons (all p>0.006). Error bars represent 1 SEM. Statistics were corrected for age and BMI. BPND, nondisplaceable binding potential; DA, dopamine.
Figure 3
Figure 3
Aggression MPQ personality scores correlated with baseline D2R in putamen (r=0.72, p=0.004; Bonferroni-corrected), VS (r=0.56, p=0.04), and at trend level in the caudate (r=0.47, p=0.09) in nonsmokers only; variables have been residualized for age and BMI. There were no significant correlations for smokers or ex-smokers. BPND, nondisplaceable binding potential; DA, dopamine; VS, ventral striatum.

Similar articles

Cited by

References

    1. Albrecht DS, Kareken DA, Yoder KK (2013). Effects of smoking on D(2)/D(3) striatal receptor availability in alcoholics and social drinkers. Brain Imag Behav 7: 326–334. - PMC - PubMed
    1. Alia-Klein N, Goldstein RZ, Kriplani A, Logan J, Tomasi D, Williams B et al (2008). Brain monoamine oxidase A activity predicts trait aggression. J Neurosci 28: 5099–5104. - PMC - PubMed
    1. Brody AL, Mandelkern MA, Olmstead RE, Allen-Martinez Z, Scheibal D, Abrams AL et al (2009). Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology 34: 282–289. - PMC - PubMed
    1. Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P et al (2004). Smoking-induced ventral striatum dopamine release. Am J Psychiatry 161: 1211–1218. - PubMed
    1. Brown AK, Mandelkern MA, Farahi J, Robertson C, Ghahremani DG, Sumerel B et al (2012). Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers. Int J Neuropsychopharmacol 15: 989–994. - PMC - PubMed

Substances

LinkOut - more resources